Two-stage, Randomized, double-blind, placebo-controlled clinical trial on the efficacy and safety of Lagundi (Vitex negundo) tablets/syrup (NIRPROMP formulation) with standard treatment compared to placebo with standard treatment in patients with mild COVID disease without comorbidities
- Funded by Philippine Council for Health Research and Development (PCHRD)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
Philippine Council for Health Research and Development (PCHRD)Research Location
PhilippinesLead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Clinical characterisation and managementResearch Subcategory
Clinical trials for disease managementSpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
Randomized Controlled TrialBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified